VAERS reports by lot

GSK Varicella/Shingles lot 44DX9: VAERS reports

20 VAERS reports list lot 44DX9 as a GSK Varicella/Shingles vaccine, received between 2021-06-08 and 2022-04-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1832%
Neurological916%
Injection-site / Local reaction814%
Musculoskeletal611%
Dermatological (non-injection-site)611%
Allergic / Anaphylactic35%
Respiratory35%
Gastrointestinal24%
Autoimmune / Immune-mediated12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
New York2
Texas2
Tennessee1
Massachusetts1
Michigan1
Wisconsin1
Minnesota1
Oregon1
Illinois1
Maine1
Pennsylvania1

Reports by month received

2021-062
2021-078
2021-082
2021-092
2021-101
2021-113
2021-121
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.